News Headlines Article

High court declines to hear Glaxo appeal
Modern Healthcare

The U.S. Supreme Court on Monday decided it will not hear an appeal brought by GlaxoSmithKline over whether insurance companies can sue the drugmaker for Medicare Advantage enrollees’ medical expenses tied to the troubled diabetes drug Avandia.

Humana Health Plans, a division of Humana won a federal appeals court ruling last year that Medicare Advantage insurers, like the federal government’s standard Medicare program, can sue companies if their products harmed enrollees and lead to additional health costs under the Medicare Secondary Payer Act.